Drug intelligence / Profile preview

glycine

Development stage
Approved
Modality
Small Molecules
Administration
Oral, Intravenous, Irrigation
01

Overview

Glycine is the simplest and smallest amino acid, with a single hydrogen atom as its side chain. It is a non-essential amino acid found in proteins such as collagen, where it constitutes about 35% of the structure. Glycine acts as an inhibitory neurotransmitter in the central nervous system, especially in the spinal cord, brainstem, and retina. It also serves as a co-agonist for NMDA receptors (excitatory) alongside glutamate. In metabolism, glycine is involved in biosynthesis of porphyrins and purines and plays a role in hepatic detoxification by conjugating with toxins to increase their solubility for excretion[1][2][5].

Brand names
Aminosyn II 7 %Sulfite-freeAminosyn-PF 7%Clinimix 2.75/5Clinimix E 2.75/5Clinisol 15Clinisol15Clinisol-15Freamine 6.9Freamine6.9Freamine-6.9Freamine III 10Hepatamine 8Hepatamine8Hepatamine-8OlimelPeriolimelPlenaminePremasolPrimeneProcalamine 3Procalamine3Procalamine-3ProsolTravasol 10Travasol10Travasol-10Trophamine 10 %GlysomBioglycineAminogex
Other names
甘氨酸aminoacetic acidglycocollglycinum
02

Targets

Glycine receptorNMDAR (Glutamate receptor ionotropic, NMDA)

Beyond the preview

Go deeper on glycine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on glycine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call